Balyasny Asset Management’s Soleno Therapeutics SLNO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$30.3M Buy
361,605
+344,273
+1,986% +$28.8M 0.05% 394
2025
Q1
$1.24M Sell
17,332
-243,993
-93% -$17.4M ﹤0.01% 1287
2024
Q4
$11.7M Buy
+261,325
New +$11.7M 0.02% 634
2024
Q3
Sell
-247,214
Closed -$10.1M 2329
2024
Q2
$10.1M Buy
247,214
+95,596
+63% +$3.9M 0.02% 637
2024
Q1
$6.49M Sell
151,618
-775,258
-84% -$33.2M 0.01% 800
2023
Q4
$37.3M Buy
926,876
+468,053
+102% +$18.8M 0.07% 262
2023
Q3
$13.5M Buy
+458,823
New +$13.5M 0.03% 536